Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Nov;52(5):719–724. doi: 10.1038/bjc.1985.249

Long-term effects of chemotherapy on lymphocyte chromosomes from patients treated for gestational trophoblastic tumours.

B R Reeves, S D Lawler, G Casey, H Harris
PMCID: PMC1977236  PMID: 2998425

Abstract

A cytogenetic follow-up study of patients treated with chemotherapy for gestational trophoblastic tumours was undertaken. In some cases, high levels of chromosome damage were found to persist in lymphocytes for several years after completion of therapy. These results are compared with those found in similar studies of non-malignant and other malignant diseases. The relevance of these findings to the risk of subsequent chemotherapy-induced malignancy is discussed.

Full text

PDF
719

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagshawe K. D. Risk and prognostic factors in trophoblastic neoplasia. Cancer. 1976 Sep;38(3):1373–1385. doi: 10.1002/1097-0142(197609)38:3<1373::aid-cncr2820380342>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  2. Bagshawe K. D. Treatment of high-risk choriocarcinoma. J Reprod Med. 1984 Nov;29(11):813–820. [PubMed] [Google Scholar]
  3. Chabner B. A. Second neoplasm--a complication of cancer chemotherapy. N Engl J Med. 1977 Jul 28;297(4):213–215. doi: 10.1056/NEJM197707282970411. [DOI] [PubMed] [Google Scholar]
  4. Einhorn N., Eklund G., Franzén S., Lambert B., Lindsten J., Söderhäll S. Late side effects of chemotherapy in ovarian carcinoma: a cytogenetic, hematologic, and statistical study. Cancer. 1982 Jun 1;49(11):2234–2241. doi: 10.1002/1097-0142(19820601)49:11<2234::aid-cncr2820491106>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  5. Gallimore P. H., Richardson C. R. An improved banding technique exemplified in the karyotype analysis of two strains of rat. Chromosoma. 1973;41(3):259–263. doi: 10.1007/BF00344020. [DOI] [PubMed] [Google Scholar]
  6. Grünwald H. W., Rosner F. Acute leukemia and immunosupressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases. Arch Intern Med. 1979 Apr;139(4):461–466. [PubMed] [Google Scholar]
  7. Lambert B., Holmberg K., Einhorn N. Persistence of chromosome rearrangements in peripheral lymphocytes from patients treated with melphalan for ovarian carcinoma. Hum Genet. 1984;67(1):94–98. doi: 10.1007/BF00270564. [DOI] [PubMed] [Google Scholar]
  8. Palmer R. G., Doré C. J., Denman A. M. Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet. 1984 Feb 4;1(8371):246–249. doi: 10.1016/s0140-6736(84)90125-9. [DOI] [PubMed] [Google Scholar]
  9. Perry P., Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature. 1974 Sep 13;251(5471):156–158. doi: 10.1038/251156a0. [DOI] [PubMed] [Google Scholar]
  10. Rustin G. J., Rustin F., Dent J., Booth M., Salt S., Bagshawe K. D. No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors. N Engl J Med. 1983 Mar 3;308(9):473–476. doi: 10.1056/NEJM198303033080901. [DOI] [PubMed] [Google Scholar]
  11. Wolff S. Difficulties in assessing the human health effect of mutagenic carcinogens by cytogenetic analyses. Cytogenet Cell Genet. 1982;33(1-2):7–13. doi: 10.1159/000131719. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES